1. Home
  2. TSVT

TSVT

2seventy bio Inc.

Logo 2seventy bio Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

Founded: 2021 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 268.4M IPO Year: N/A
Target Price: $10.60 AVG Volume (30 days): 1.5M
Analyst Decision: Buy Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -4.42 EPS Growth: N/A
52 Week Low/High: $1.54 - $12.69 Next Earning Date: 05-01-2024
Revenue: $100,387,000 Revenue Growth: 9.72%
Revenue Growth (this year): -15.9% Revenue Growth (next year): 23.56%

Share on Social Networks: